ArticleFrontiers in immunology2026

Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?

Linda Cerbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.